Evidence map›Paper›PMID 37957524›Full record

ArticleThe Journal of rural health : official journal of the American Rural Health Association and the National Rural Health Care Association2024

Locations of COVID-19 vaccination provision: Urban-rural differences.

Grace W Ryan, Amanda R Kahl, Don Callaghan, Bethany Kintigh, Natoshia M Askelson

Abstract read
In one paragraph

Article in The Journal of rural health : official journal of the American Rural Health Association and the National Rural Health Care Association, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Grace W RyanDepartment of Population and Quantitative Health Sciences, University of Massachusetts Chan Medical School, Worcester, Massachusetts, USA.ORCID 0000-0002-0354-2644
Amanda R KahlDepartment of Epidemiology, University of Iowa College of Public Health, Iowa City, Iowa, USA.
Don CallaghanBureau of Immunization & TB, Iowa Health and Human Services, Des Moines, Iowa, USA.
Bethany KintighBureau of Immunization & TB, Iowa Health and Human Services, Des Moines, Iowa, USA.
Natoshia M AskelsonDepartment of Community and Behavioral Health, University of Iowa College of Public Health, Iowa City, Iowa, USA.

Funding

University of Iowa Prevention Research Center for Rural HealthU48DP006389 · DP · UNIVERSITY OF IOWA · PI AFIFI, RIMA · 2018 to 2023
$7.4M
Prevention And Control of Cancer: Training for Change in Individuals and SystemsT32CA172009 · NCI · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI LEMON, STEPHENIE C., OCKENE, JUDITH K · 2019 to 2023
$1.5M
CDC HHS U48 DP006389NCCDPHP CDC HHS U48 DP006389NCI NIH HHS T32 CA172009NCI NIH HHS T32CA172009
6 · The paper itself

Abstract

purposeOur goal was to compare locations of COVID-19 vaccine provision in urban and rural communities over the course of the pandemic.

methodsWe used the Iowa Immunization Registry Information System (IRIS) to identify the organizations providing COVID-19 vaccines (eg, pharmacies, public health departments, and medical providers). Proportions of first-dose vaccines by organization type and patient census-based statistical area were generated. We calculated Chi-square tests to assess differences among metropolitan, micropolitan, and noncore communities.

findingsIRIS data revealed that 64% (n = 2,043,251) of Iowans received their first COVID-19 vaccine between December 14, 2020, and December 31, 2022. For metropolitan-dwelling individuals, most first doses were administered at pharmacies (53%), with similar trends observed for micropolitan (49%) and noncore (42%) individuals. The second most common location for metropolitan individuals was medical practices (17%); public health clinics and departments were the second most common provider for micropolitan (26%) and noncore (33%) individuals. These trends shifted over time. In December 2020, hospitals were the most common vaccine provider for everyone, but by December 2022, medical providers were the most common source for metropolitan individuals, and pharmacies were most common for micropolitan and noncore individuals.

conclusionsTrends in the type of vaccine provider differentiated metropolitan residents from micropolitan and noncore residents. For the latter groups, local public health departments played a more significant role. Across all groups, pharmacists emerged as a critical vaccine provider. Our findings can be used to plan for seasonal vaccine campaigns as well as potential future mass vaccination campaigns.

Indexed as

COVID-19COVID-19 VaccinesRural PopulationSARS-CoV-2Urban PopulationAdolescentAdultAgedFemaleHumansIowaMaleMiddle AgedPandemicsVaccinationCOVID-19 VaccinesCOVID‐19 vaccinationimmunization registryurban‐rural inequities

Identifiers

PMID37957524
PMCPMC11089067

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.